{
  "id": "acd38364195e4f37",
  "title": "STAT+: Hims & Hers will stop selling compounded version of Novo\u2019s obesity pill",
  "description": "Hims &#038; Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk's obesity pill on its telehealth platform.",
  "content": "Hims &#038; Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk's obesity pill on its telehealth platform.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/07/hims-wont-sell-compounded-obesity-pill-novo/?utm_campaign=rss",
  "published_at": "2026-02-07T21:14:11+00:00",
  "fetched_at": "2026-02-08T00:36:26.400151+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Hims & Hers will stop selling compounded version of Novo\u2019s obesity pill",
    "description": "Hims &#038; Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk's obesity pill on its telehealth platform.",
    "url": "https://www.statnews.com/2026/02/07/hims-wont-sell-compounded-obesity-pill-novo/?utm_campaign=rss",
    "published": "2026-02-07T21:14:11+00:00",
    "source": "STAT"
  }
}